Brenna Rowan, PharmD, BCOP

home / authors / brenna-rowan-pharmd-bcop

Articles

B-cell lymphoma -- Image credit: Arif Biswas | stock.adobe.com

Bispecific T-Cell–Engaging Antibodies in B-Cell Lymphoma: Efficacy, Safety, and Practical Considerations

Uvette Lou, PharmD, BCOP;Brenna Rowan, PharmD, BCOP;Abigail McLaren, PharmD, MS;E. Bridget Kim, PharmD, BCPS, BCOP;Mark N. Sorial, PharmD, BCOP;J. Erika Haydu, MD, PhD;Matthew M. Lei, PharmD, BCOP
August 16th 2024

This article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.

Read More

Latest Updated Articles

Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
Anatomy of Human Heart on medical background. 3d render - Image credit: ckybe | stock.adobe.com
Published: March 10th 2025 | Updated: March 21st 2025
Pharmacists Will Play an Essential Role in Optimizing Vutrisiran Therapy for ATTR-CM
Image credit: toeytoey | stock.adobe.com
Published: March 12th 2025 | Updated: March 18th 2025
MDMA Rejected: The Story of a Study Participant Entrenched in Ethical Violations
Blood test for graft-vs-host-disease (GVHD) -- Image credit: MdBabul | stock.adobe.com
Published: February 26th 2025 | Updated: March 14th 2025
Navigating Steroid-Refractory GVHD Treatment: A Pharmacist’s Guide to Medication Management
fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com
Published: March 7th 2025 | Updated: March 10th 2025
FDA Approves Interchangeable Biosimilar to Xolair
Benjamin Franklin on US dollar surrounded by pills | Image Credit: © Cagkan - stock.adobe.com
Published: January 22nd 2025 | Updated: January 28th 2025
Reversal of Executive Order 14087 Raises Questions About Future Drug Pricing Reforms